Adherence to ASCO/CAP HER2 Testing Guidelines: Equivocal Rates and Impact on Management within a Single Institution

被引：0
|
作者：
Portier, B. P.
Downs-Kelly, E.
Lanigan, C.
Cotta, C.
Patil, D.
Procop, G.
Cook, J. R.
Moore, H.
Budd, G. T.
Tubbs, R. R.
机构：
[1] Cleveland Clin, Cleveland, OH USA
[2] Taussig Canc Inst, Cleveland, OH USA
来源：
LABORATORY INVESTIGATION | 2011年 / 91卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1856
引用
收藏
页码：436A / 436A
页数：1
相关论文
共 50 条
  • [21] The New Equivocal: Changes To HER2 FISH Results When Applying the 2013 ASCO/CAP Guidelines
    Long, Thomas
    Lawce, Helen
    Durum, Connie
    Moore, Stephen
    Olson, Susan
    Gatter, Ken
    MODERN PATHOLOGY, 2015, 28 : 54A - 55A
  • [22] Impact of the Updated 2018 ASCO/CAP HER2 Guidelines: A Retrospective Study
    Wu, Jessie
    Mullen, Brendan
    Mrkonjic, Miralem
    Turashvili, Gulisa
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 287 - 288
  • [23] Impact of the Updated 2018 ASCO/CAP HER2 Guidelines: A Retrospective Study
    Wu, Jessie
    Mullen, Brendan
    Mrkonjic, Miralem
    Turashvili, Gulisa
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 287 - 288
  • [24] Impact of 2013 ASCO/CAP Guidelines on HER2 Determination of Invasive Breast Cancer: A Single Institution Experience Using Frontline FISH
    Ragazzi, Moira
    Bisagni, Alessandra
    Bassano, Cristina
    Tamagnini, Ione
    Gasparini, Elisa
    Kuhn, Elisabetta
    Gardini, Giorgio
    LABORATORY INVESTIGATION, 2016, 96 : 68A - 68A
  • [25] Impact of 2013 ASCO/CAP Guidelines on HER2 Determination of Invasive Breast Cancer: A Single Institution Experience Using Frontline FISH
    Ragazzi, Moira
    Bisagni, Alessandra
    Bassano, Cristina
    Tamagnini, Ione
    Gasparini, Elisa
    Kuhn, Elisabetta
    Gardini, Giorgio
    MODERN PATHOLOGY, 2016, 29 : 68A - 68A
  • [26] Impact of Genetic Heterogeneity on HER2 Status with Implementation of the 2013 ASCO/CAP HER2 Reporting Guidelines
    Estrada, Monica V.
    Kuba, Maria G.
    Rexer, Brent
    Manning, Suzanne
    Wheeler, Ferrin
    Yenamandra, Ashwini
    Sanders, Melinda E.
    LABORATORY INVESTIGATION, 2016, 96 : 41A - 41A
  • [27] Impact of Genetic Heterogeneity on HER2 Status with Implementation of the 2013 ASCO/CAP HER2 Reporting Guidelines
    Estrada, Monica V.
    Kuba, Maria G.
    Rexer, Brent
    Manning, Suzanne
    Wheeler, Ferrin
    Yenamandra, Ashwini
    Sanders, Melinda E.
    MODERN PATHOLOGY, 2016, 29 : 41A - 41A
  • [28] Evaluation of the Clinical Implementation of the 2013 CAP/ASCO HER2 FISH Testing Guidelines
    Kang, S. -H. L.
    Lillemoe, T. J.
    Grimm, E. V.
    Susnik, B.
    Swenson, K. K.
    Tsai, M. L.
    CYTOGENETIC AND GENOME RESEARCH, 2014, 142 (03)
  • [29] The updated ASCO/CAP guidelines for HER2 testing create more uncertainty for clinicians
    Chen, J.
    Klein, P.
    Shao, T.
    CANCER RESEARCH, 2016, 76
  • [30] Impact of the 2013 ASCO/CAP Guideline Recommendations for HER2 Testing of Invasive Breast Carcinoma: A Focus on Tumors Assessed as Equivocal for HER2 Gene Amplification By FISH
    Bethune, Gillian
    van Zanten, Daniel Veldheijzen
    Younis, Tallal
    Rayson, Daniel
    Thompson, Kara
    Barnes, Penny
    MODERN PATHOLOGY, 2015, 28 : 35A - 35A
12345